Reported 5 months ago
Cathie Wood, known for her aggressive growth stock strategies, continues to fine-tune her collection of growth stocks by adding to her existing positions in Shopify, Intellia Therapeutics, and Adaptive Biotechnologies. Despite a challenging year in 2024, Wood sees potential opportunities in these stocks, which are trading 16% to 29% lower. Shopify, a top holding, has experienced a stock decline due to decelerating growth despite strong financial results, while Intellia and Adaptive Biotechnologies hold promise in gene-editing therapies. Wood's strategic moves reflect a long-term growth perspective amidst market fluctuations.
Source: YAHOO